Mathias Faßhauer
Faßhauer, Mathias 1974-
VIAF ID: 907992 (Personal)
Permalink: http://viaf.org/viaf/907992
Preferred Forms
- 100 1 _ ‡a Faßhauer, Mathias ‡d 1974-
- 100 1 _ ‡a Faßhauer, Mathias ‡d 1974-
- 100 0 _ ‡a Mathias Faßhauer
4xx's: Alternate Name Forms (1)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
Adipozytensignaltransduktion und Adipokine als Verbindung zwischen Adipositas und Insulinresistenz | |
Einfluß der Organisation des Mikrofilamentsystems auf die Synthese von Proto-Onkogen-Proteinen und Cyclinen | |
Isoproterenol inhibits resistin gene expression through a G(S)-protein-coupled pathway in 3T3-L1 adipocytes | |
Isoproterenol, TNFalpha, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytes | |
Leptin decreases circulating inflammatory IL-6 and MCP-1 in mice | |
Leptin dose-dependently decreases atherosclerosis by attenuation of hypercholesterolemia and induction of adiponectin. | |
Leptin restores markers of female fertility in lipodystrophy | |
Leptin secretion and negative autocrine crosstalk with insulin in brown adipocytes | |
Leptin Substitution in Patients With Lipodystrophy: Neural Correlates for Long-term Success in the Normalization of Eating Behavior | |
Leptin Within the Subphysiological to Physiological Range Dose Dependently Improves Male Reproductive Function in an Obesity Mouse Model | |
Lipocalin-2 is induced by interleukin-1beta in murine adipocytes in vitro | |
Lipodystrophie-Erkrankungen | |
[Lipodystrophy. Mechanisms, clinical presentation, therapy] | |
Magnetresonanztomographische Quantifizierung abdomineller Fettkompartimente und deren Assoziation zu Insulinresistenz, Leptin und Vaspin in der Allgemeinbevölkerung | |
Metformin inhibits leptin secretion via a mitogen-activated protein kinase signalling pathway in brown adipocytes | |
Neurohumoral stimulation in type-2-diabetes as an emerging disease concept | |
Novel adipocyte lines from brown fat: a model system for the study of differentiation, energy metabolism, and insulin action | |
The novel adipokine/hepatokine fetuin B in severe human and murine diabetic kidney disease. | |
The novel missense mutation methionine 442 threonine in the thyroid hormone receptor beta causes thyroid hormone resistance: a case report | |
Novel peroxisome proliferator-activated receptor gamma mutation in a family with familial partial lipodystrophy type 3. | |
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans | |
Positive and negative roles of p85α and p85β regulatory subunits of phosphoinositide 3-kinase in insulin signaling | |
Preliminary report: Serum levels of retinol-binding protein 4 in preeclampsia | |
Pro-Neurotensin depends on renal function and is related to all-cause mortality in chronic kidney disease | |
Progranulin is increased in human and murine lipodystrophy. | |
Proinflammatory adipocytokines induce TIMP-1 expression in 3T3-L1 adipocytes | |
Putting fat cells onto the road map to novel therapeutic strategies | |
Relationship between twelve adipocytokines and distinct components of the metabolic syndrome. | |
Repin1 maybe involved in the regulation of cell size and glucose transport in adipocytes | |
Secretory products from human adipocytes stimulate proinflammatory cytokine secretion from human endothelial cells | |
Serum adiponectin and progranulin levels are associated with gallstone disease | |
Serum amyloid A3 expression is stimulated by dexamethasone and interleukin-6 in 3T3-L1 adipocytes | |
Serum concentrations of fetuin B in lipodystrophic patients. | |
Serum levels of adipocyte fatty acid-binding protein are decreased in chronic pancreatitis. | |
Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis | |
Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction | |
Serum levels of sclerostin in cardiometabolic disorders during pregnancy. | |
Serum levels of the adipokine Pref-1 in gestational diabetes mellitus | |
Serum levels of the adipokine zinc-α2-glycoprotein are increased in preeclampsia | |
Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease | |
Serum levels of the myokine irisin in relation to metabolic and renal function | |
Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue | |
Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass | |
Serum vaspin concentrations are decreased after exercise-induced oxidative stress. | |
Suppression of aquaporin adipose gene expression by isoproterenol, TNFalpha, and dexamethasone | |
Systematic comparison of sporadic and syndromic pancreatic islet cell tumors | |
Therapeutic perspectives of adipocytokines | |
Tissue inhibitor of metalloproteinase-1 predicts adiposity in humans. | |
Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays | |
Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes | |
Tumor necrosis factor-related apoptosis-inducing ligand and cardiovascular disease | |
Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes | |
Visfatin is a positive regulator of MCP-1 in human adipocytes in vitro and in mice in vivo | |
Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine | |
What are subcutaneous adipocytes really good for? |